This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.

Sponsored by Sensus Healthcare

About this trial

Last updated 7 years ago

Study ID

SRTS-SRT-002

Status

Unknown status

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 6 years ago

What is this trial about?

Keloid formation in response to skin trauma inflicts about 18 million individuals. A key impediment in successful treatment of keloids is that the predominant treatments, particularly surgical excision and shaving, tend to initiate the regrowth of the keloid at the excision site, and therefore, recurrence rates are high. There is much evidence to demonstrate that following surgical excision procedures with a course of radiation therapy can significantly reduce recurrence rates to as little as 10% or below. This retrospective study is to evaluate this claim.

What are the participation requirements?

Yes

Inclusion Criteria

- Confirmed diagnosis of keloid(s).

- Treatment with SRT-100™ of one or more keloids.

- At least 1 year since treatment end.

- Required retrospective data is existing and sufficient.

No

Exclusion Criteria

- Lesions of etiology other than keloids.